CD33 and acute myeloid leukemia: We further evaluated the dose-dependent cytotoxicity of the 123b-33bcCAR by progressively decreasing the E:T ratio against two other AML cell lines: KG1a (CD123+CD33+) and HL60 (CD123dimCD33+).